• 166049 Citations
  • 186 h-Index
1981 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hagop M Kantarjian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 37 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Achieving complete remission in CLL patients treated with ibrutinib: Clinical significance and predictive factors

Strati, P., Schlette, E. J., Solis Soto, L. M., Duenas, D. E., Sivina, M., Kim, E., Keating, M. J., Wierda, W. G., Ferrajoli, A., Kantarjian, H., Estrov, Z., Jain, N., Thompson, P. A., Wistuba, I. I. & Burger, J. A., Feb 13 2020, In : Blood. 135, 7, p. 510-513 4 p.

Research output: Contribution to journalLetter

1 Scopus citations

A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia

Bose, P., Verstovsek, S., Cortes, J. E., Tse, S., Gasior, Y., Jain, N., Jabbour, E. J., Estrov, Z., Alvarado, Y., DiNardo, C. D., Pemmaraju, N., Kornblau, S. M., Kadia, T. M., Daver, N. G., Naqvi, K., Short, N. J., Masarova, L., Villareal, J., Pierce, S. A., Nogueras-Gonzalez, G. & 4 others, Huang, X., Garcia-Manero, G., Kantarjian, H. M. & Ravandi, F., Sep 1 2020, In : Leukemia. 34, 9, p. 2489-2492 4 p.

Research output: Contribution to journalLetter

1 Scopus citations

Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome–positive B-precursor acute lymphoblastic leukemia

Rambaldi, A., Ribera, J. M., Kantarjian, H. M., Dombret, H., Ottmann, O. G., Stein, A. S., Tuglus, C. A., Zhao, X., Kim, C. & Martinelli, G., Jan 15 2020, In : Cancer. 126, 2, p. 304-310 7 p.

Research output: Contribution to journalArticle

Open Access
  • 8 Scopus citations
    Open Access